Please enable Javascript
Blood Cancer Talks
This podcast focuses exclusively on the management of blood cancers and hematology. The twice-monthly episodes are hosted by Rajshekhar Chakraborty, MD; Ashwin Kishtagari, MD; and Edward Cliff, MD.
Advertisement
Martin Dreyling, MD, Talks TRIANGLE Trial, MCL Management
Blood Cancer Talks
Mantle Cell Lymphoma
|
May 19, 2023
Dr. Dreyling discusses the management of newly diagnosed MCL and considerations in light of the TRIANGLE trial.
Listen Now
How is MM Managed in LMICs?
Blood Cancer Talks
Blood Cancer Talks
|
May 19, 2023
The episode was inspired by an article titled “The Underrepresented Majority" by Andrés Gómez-De León, MD.
Listen Now
Ayalew Tefferi, MD, on Risk Stratification, Treatment Considerations for Myelofibrosis
Blood Cancer Talks
Blood Cancer Talks
|
May 19, 2023
Dr. Tefferi discusses risk stratification systems for primary myelofibrosis, transplant considerations, and more.
Listen Now
Morie Gertz, MD, on Clinical Trials and Controversies in Smoldering MM
Blood Cancer Talks
Blood Cancer Talks
|
May 19, 2023
Dr. Gertz and the hosts provide an overview of risk-stratification approaches and clinical trials in smoldering MM.
Listen Now
Amy DeZern, MD, MHS, on the RACE Trial, Treatment Strategies for Acquired Aplastic Anemia
Blood Cancer Talks
Blood Cancer Talks
|
May 19, 2023
Dr. DeZern discusses the latest research in the management of acquired aplastic anemia.
Listen Now
Anand Patel, MD, on the ASAP Trial, Menin Inhibitors, and Key ASH Updates
Blood Cancer Talks
Blood Cancer Talks
|
May 19, 2023
Dr. Patel and the hosts discuss the phase III ASAP and Dauno-Double trials, menin inhibitors, and more.
Listen Now
Advertisement
What Are the Latest Treatment Strategies for Newly Diagnosed DLBCL?
Blood Cancer Talks
Blood Cancer Talks
|
May 19, 2023
This episode provides listeners with DLBCL management strategies and an overview of the latest research in the field.
Listen Now
Luciano Costa MD, PhD, on the MASTER Trial and MRD Considerations in MM
Blood Cancer Talks
Blood Cancer Talks
|
May 19, 2023
Dr. Costa discusses the multiple uses of MRD in MM.
Listen Now
What Are the Key Trials in Younger Adults with Newly Diagnosed AML?
Blood Cancer Talks
Blood Cancer Talks
|
May 19, 2023
Dr. Stein discusses research on the impact of treatment delays, the RATIFY trial, and more.
Listen Now
Advertisement
Advertisement
Editorial Board
Sagar Lonial, MD, FACP
Editor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine
Guillermo Garcia-Manero, MD
Associate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center
Elias Jabbour, MD
Associate Editor | Professor in the Department of Leukemia, Division of Cancer Medicine, MD Anderson Cancer Center
Kami Maddocks, MD
Associate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University
Thomas Martin, MD
Associate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center
Jerald Radich, MD
Associate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch
Laurie Sehn, MD, MPH
Associate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer